BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 54 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,605,000 | -4.5% | 1,445,000 | -0.4% | 0.00% | 0.0% |
Q1 2016 | $1,680,000 | -9.4% | 1,451,000 | +0.4% | 0.00% | 0.0% |
Q4 2015 | $1,855,000 | -0.6% | 1,445,000 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $1,867,000 | -16.2% | 1,445,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $2,227,000 | +3.6% | 1,445,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $2,150,000 | +60.4% | 1,445,000 | +26.8% | 0.00% | +50.0% |
Q4 2014 | $1,340,000 | +11.0% | 1,140,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $1,207,000 | -4.0% | 1,140,000 | -6.2% | 0.00% | 0.0% |
Q2 2014 | $1,257,000 | +18.1% | 1,215,000 | +25.1% | 0.00% | 0.0% |
Q1 2014 | $1,064,000 | +21.3% | 971,000 | +17.3% | 0.00% | +100.0% |
Q4 2013 | $877,000 | – | 828,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MACKAY SHIELDS LLC | 37,179,000 | $41,455,000 | 2.06% |
LINDEN ADVISORS LP | 24,592,000 | $27,360,000 | 1.20% |
SHENKMAN CAPITAL MANAGEMENT INC | 12,025,000 | $13,415,000 | 1.15% |
Ferox Capital Management LP | 3,465,000 | $3,889,000 | 1.09% |
OAKTREE CAPITAL MANAGEMENT LP | 44,823,000 | $49,860,000 | 0.90% |
ADVENT CAPITAL MANAGEMENT /DE/ | 40,514,000 | $45,097,000 | 0.70% |
RWC Asset Management LLP | 7,500,000 | $8,322,000 | 0.53% |
CSS LLC/IL | 4,196,000 | $4,653,000 | 0.31% |
SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $2,231,000 | 0.24% |
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 3,750,000 | $4,176,000 | 0.19% |